|
C9ORF80 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.98180005318261E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.37650004914536E-09 |
| Normal-vs-Stage2 |
1.994140E-04 |
| Normal-vs-Stage3 |
2.039200E-04 |
| Normal-vs-Stage4 |
2.829700E-02 |
| Stage1-vs-Stage2 |
2.871000E-01 |
| Stage1-vs-Stage3 |
7.510400E-01 |
| Stage1-vs-Stage4 |
7.915600E-01 |
| Stage2-vs-Stage3 |
6.323600E-01 |
| Stage2-vs-Stage4 |
7.517000E-01 |
| Stage3-vs-Stage4 |
9.514800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.95160004718065E-09 |
| Normal-vs-AfricanAmerican |
9.81629999999845E-05 |
| Normal-vs-Asian |
7.834600E-04 |
| Caucasian-vs-AfricanAmerican |
2.859800E-01 |
| Caucasian-vs-Asian |
6.804000E-01 |
| AfricanAmerican-vs-Asian |
4.493600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.56340007185474E-10 |
| Normal-vs-Female |
1.077450E-03 |
| Male-vs-Female |
1.437610E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.71600000051531E-07 |
| Normal-vs-Extreme_Weight |
6.84170498033154E-11 |
| Normal-vs-Obese |
1.766630E-04 |
| Normal-vs-Extreme_Obese |
1.263160E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.081000E-01 |
| Normal_Weight-vs-Obese |
2.033200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.167400E-01 |
| Extreme_Weight-vs-Obese |
2.966000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.919410E-01 |
| Obese-vs-Extreme_Obese |
9.553600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.98079999999845E-06 |
| Normal-vs-Age(41-60Yrs) |
2.21229999999295E-05 |
| Normal-vs-Age(61-80Yrs) |
1.67449998311753E-09 |
| Normal-vs-Age(81-100Yrs) |
1.07940000004803E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.296980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.316200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.255000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.454300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.320020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.395400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.25910004223596E-09 |
| Normal-VS-Type2 PRCC |
2.37270000003065E-06 |
| Normal-VS-KIRP CIMP |
1.752620E-04 |
| Normal-VS-Unclassified PRCC |
4.301600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.232400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.525800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.724400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.942000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.384600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.632400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67070000056668E-08 |
| Normal-vs-N1 |
7.322500E-03 |
| Normal-vs-N2 |
8.387400E-04 |
| N0-vs-N1 |
2.231200E-01 |
| N0-vs-N2 |
6.321800E-01 |
| N1-vs-N2 |
3.876600E-01 |
|
|
